Oncopeptides

Oncopeptides publishes case reports on Pepaxti

Oncopeptides | Investing in Life Science 2025

CFO Henrik Bergentoft presents Oncopeptides at Investing in...

Issue outcome signals recovery for biotech

After years of struggling to...

Tailwind and emission will take Oncopeptides into the black

Oncopeptides, which is currently in the process of issuing shares, has the wind in its sails. The European launch of...

Oncopeptides: “We are in a huge growth phase”

Oncopeptides is in an expansive phase with...

BioStock Investor Pitch: Oncopeptides

Oncopeptides strengthens its grip on the European market with...

Oncopeptides presents real-world data for Pepaxti at IMS

Oncopeptides CEO comments on the company's strong momentum

With continued progress in the commercialization of Pepaxti in...

Oncopeptides carries out a share issue of SEK 150 million

Oncopeptides enters partnership with SD Pharma in Spain

Oncopeptides CEO: “It is a crucial validation of Pepaxti's clinical benefit”

Oncopeptides recently reached an important milestone with Pepaxti,...